echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Pioneer Pharmaceuticals Prokalutamide reduces the risk of death in clinical trials for patients with severe new crown by 92%

    Pioneer Pharmaceuticals Prokalutamide reduces the risk of death in clinical trials for patients with severe new crown by 92%

    • Last Update: 2021-07-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com




      Procramide treatment group

     

    (N=294)

    Placebo control group

     

    (N=296)

      Number of people percentage Number of people percentage
    mortality rate 11 3.


    (Median time)

    5 days 14 days
    New use of ventilator 13 4.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.